JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; "JCR") announced today that the Company presented preclinical data from its novel adeno-associated virus (AAV) gene ...

MeiraGTx (MGTX) announced the Company will exhibit five posters at the European Society of Gene and Cell Therapy, ESGCT, 2024 Annual Congress, ...

Taysha Gene Therapies (TSHA) will present biodistribution data from an analysis of 28 non-human primates evaluating the delivery of AAV9 gene ...

(Alliance News) - Syncona Ltd on Wednesday noted positive trial results for a portfolio company's gene therapy aimed at treating people with Gaucher's disease.

The Association des optométristes du Québec (AOQ) regretfully announces that 85% of its members have decided to withdraw from ...

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that enrollment is complete for ...

Gov. Kathy Hochul on Tuesday announced a $150 million investment in a new state-of-the-art cell and gene therapy hub to be built on Long Island.

Visiting Nassau County on Tuesday, Gov. Kathy Hochul announced plans for the New York BioGenesis Park, a $430 million, ...

A 12-year-old boy has become the first patient in the U.S. to receive gene therapy for sickle cell disease, The New York Times reported Oct ...

Fucosidosis Therapeutics MarketThe global Fucosidosis Therapeutics Market is projected to grow significantly, reaching a market value of USD 17.91 Million by 2033, up from USD 10 Million in 2023, ...

The gene editing company will focus on “in vivo” medicines, while seeking to license out or find a development partner for its clinical-stage treatment reni-cel.

Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information ...